(Q43257116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

R A de Boer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

F M A C Martens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

I Kuipers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

F Boomsma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

74-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

Metabolic and additional vascular effects of thiazolidinediones.

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Effects of thiazolidinediones on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

TNF-α induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-γ agonist pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

Effects of the PPAR-gamma agonist rosiglitazone on renal haemodynamics and the renin-angiotensin system in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.84

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JHH.2009.84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19847195%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 February 2020

1028235441

0 references

1 reference